Theseus Pharmaceuticals, Inc. (THRX) Cash Flow Annual - Discounting Cash Flows
THRX
Theseus Pharmaceuticals, Inc.
THRX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing: 2023-11-17 2023-03-09 2022-03-10 2020-12-31 2019-12-31
Net Income/Starting Line -56.61 -50.61 -27.31 -12 -7.18
Cash From Operating Activities -49.63 -32.95 -27.19 -4.85 -4.81
Depreciation and Amortization 0.083 0.05 0.002 0.002 0.002
Deferred Income Tax -2.98 0 -4.36 0 0
Stock Based Compensation 12.58 11.41 4.36 1.05 0.317
Other Non-Cash Items -0.712 -0.35 4.36 5.16 2.24
Changes in Working Capital -2 6.55 -4.25 0.933 -0.179
Accounts Receivable 0 0 0 0 0
Inventory 0 0 0 0 0
Accounts Payable -0.507 3.97 -0.15 0.849 0.193
Deferred Revenue 4.97 2.58 -4.1 0.084 -0.372
Other Working Capital -6.46 0 0 0 0
Cash From Investing Activities -68.76 -117.3 0.012 0 0
Investments in Property Plant and Equipment -0.061 -0.455 0.012 0 0
Payments for Acquisitions 166.9 0.117 0 0 0
Purchases of Securities -185.8 -191.4 0 0 0
Sales and Maturities of Investments 117.1 74.6 0 0 0
Other Investing Activities -167 -0.117 0 0 0
Cash From Financing Activities 49.63 0 263.8 11.99 2.99
Debt Repayment 0 0 0 0 0
Common Stock Issued 49.58 0 166.2 11.99 2.99
Common Stock Repurchased 0 0 0 0 0
Dividends Paid 0 0 0 0 0
Other Financing Activities 49.74 0.182 263.8 11.99 2.99
Effect of Forex Changes on Cash 0 0 -0.012 0 0
Net Change in Cash -47.69 -150.1 236.6 7.14 -1.81
Cash at Beginning of Period 94.98 245 8.46 1.32 3.13
Cash at End of Period 47.29 94.98 245 8.46 1.32
Free Cash Flow -49.69 -33.4 -27.18 -4.85 -4.81
Operating Cash Flow -49.63 -32.95 -27.19 -4.85 -4.81
Capital Expenditure -0.061 -0.455 0.012 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program